Best Value Stocks For 2018

Small cap extreme-value retailer (for pre-teens, teens and beyond) Five Below Inc (NASDAQ: FIVE) reportedQ2 2017 earnings after the Wednesday market close with results beating expectations thanks todemand for fidget spinner toys plus the Company lifted full-year guidance above consensus estimates. Net sales increased by 25.0% to $516.2 million as comparable sales increased by 6.1%. Net income was $25.2 million versus $16.6 million. The CEO commented:

“Our strong second quarter results demonstrate the amazing appeal of the Five Below brand. We exceeded the high end of our sales, comp and earnings outlook. Sales growth of 29% was led by strong new store performance and our transaction-driven comp of 9.3%, which was the highest since our IPO. We saw solid broad-based performance across our worlds, with notable contribution from the spinner trend. Our top line results were accompanied by strong margin expansion, resulting in over 70% net income growth.”

Best Value Stocks For 2018: Skechers U.S.A., Inc.(SKX)

Advisors’ Opinion:

  • [By Teresa Rivas]

    Skechers (SKX) is higher on Friday following its fourth-quarter earnings report.

    Getty Images

    Both the companys quarter and guidance were mixed, with higher-than-expected sales, but a downbeat bottom line. The shoe company said that it earned 4 cents a share on revenue that rose 5.8% year over year to $764.3 million. Analysts were expecting a dime per share in earnings on revenue of $726.2 million.

    For the first quarter, the company said it expects to earn between 50 cents and 55 cents a share, below the 66 cents analysts were expecting. However its revenue estimate of $1.05 billion to $1.08 billion was above the $1.05 that analyst are modeling for.

    Wedbushs Christopher Svezia reiterated Neutral rating and $25 price target on the stock, arguing that while hes encouraged by top-line trends, theyre coming at a cost. From his note:

    Shares will likely trade higher (+9% after hours) given the improved revenue outlook and what may have been a low bar on expectations. However, sales growth is not translating into earnings and the inflection continues to move further out, increasing risk should growth not materialize. We are maintaining our NEUTRAL rating and $25 price target or 14x P/E, a 10% discount to historical averages until we see visibility toward an inflection in earnings growth.

    Skechers is up 20% to $27.95 in recent afternoon trading.

  • [By Lisa Levin]

    Shares of Skechers USA Inc (NYSE: SKX) were down 28 percent to $30.42. Skechers reported in-line earnings for its first quarter, but issued weak guidance for the second quarter.

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link

    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

Best Value Stocks For 2018: Ashford Hospitality Trust Inc(AHT)

Advisors’ Opinion:

  • [By Lisa Levin] Related AHT 25 Biggest Mid-Day Gainers For Friday Mid-Day Market Update: Hortonworks Drops Following Weak Results; Freshpet Shares Spike Higher Ashford Hospitality Trust's (AHT) CEO Montgomery Bennet on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related NEWS Mid-Morning Market Update: Markets Open Higher; Micron To Lower Jobs Mid-Morning Market Update: Markets Open Lower; Broadcom Profit Beats Expectations NewStar Financial's (NEWS) CEO Tim Conway on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)

     

Best Value Stocks For 2018: Veeva Systems Inc.(VEEV)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Elite Opportunity Pronewsletter suggested mid cap global life sciencescloud-based software solutions stock Veeva Systems Inc (NYSE: VEEV) as a bullish long trade for investors who have patience:

  • [By Jim Crumly]

    Cloud software vendor Veeva Systems (NYSE:VEEV) has had some extraordinary success selling its products to companies in the life sciences. It is now preparing to extend its reach into other industries, and long-term investors should be excited about the potential for the long runway of growth that could result.

  • [By Keith Speights, Brian Stoffel, and George Budwell]

    Healthcare is changing rapidly. Which companies will emerge as the huge winners with these major changes? We asked three of our healthcare contributors to weigh in on the subject. Here’s whyAbbVie (NYSE:ABBV),Alphabet (NASDAQ:GOOGL) (NASDAQ:GOOG), Johnson & Johnson (NYSE:JNJ), and Veeva Systems (NYSE:VEEV) could represent bold bets on the future of healthcare.

  • [By Brian Stoffel]

    To say that Veeva Systems (NYSE:VEEV) has performed well as a publicly traded company would be an understatement. While the stock itself is actually down since its post-IPO days, the company’s fundamentals have vastly improved during that time frame.

Best Value Stocks For 2018: Synta Pharmaceuticals Corp.(SNTA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Synta Pharmaceuticals Corp. (NASDAQ: SNTA) shares were also up, gaining 61 percent to $0.393. Synta Pharmaceuticals announced plans to merge with privately-held Madrigal Pharmaceuticals.

Best Value Stocks For 2018: HSBC Holdings plc(HSBC)

Advisors’ Opinion:

  • [By Money Morning News Team]

    And the Aramco IPO is making progress. On Feb. 7, the Saudi Arabian oil company hired Moelis & Co. (NYSE:MC) as its IPO advisor. Then on Feb. 21, the company hired the lead underwriters for the IPO. Wall Street stalwarts JPMorgan Chase & Co. (NYSE: JPM), Morgan Stanley (NYSE: MS), and HSBC Holdings Plc. (NYSE ADR: HSBC) won the lucrative underwriting contracts.

  • [By Elizabeth Balboa]

    Here are the top 10 financial bodies investing in lobbying in 2017:

    American Bankers Association: $5.6 million
    Securities Industry & Financial Market Association: $3.5 million
    Financial Services Roundtable: $3.0 million
    Independent Community Bankers of America: $2.7 million
    Association of International CPAs: $2.6 million
    Citigroup Inc (NYSE: C): $2.5 million
    Investment Company Institute: $2.4 million
    S&P Global Inc (NYSE: SPGI): $2.4 million
    Credit Union National Association: $2.4 million
    HSBC Holdings plc (ADR) (NYSE: HSBC): $2.4 million

    Dozens of others spent more than $1 million, including Ally Financial Inc (NYSE: ALLY), Visa Inc (NYSE: V) and Navient Corp (NASDAQ: NAVI).

  • [By WWW.THESTREET.COM]

    Up first on our list of financial sector breakout trades is $156 billion global bank HSBC Holdings plc (HSBC) . Don’t get fooled by the headline numbers in HSBC this year – shares may be hovering around breakeven year-to-date, but they’re up more than 35% from their April lows. And after tracking sideways for the last couple of months, HSBC is back in breakout mode this week.